Tag Archives: LLY

Top 5 Clean Energy Stocks To Invest In 2018

Quest’s Profitable Moment

President Donald Trump is going to Davos for the World Economic Forum — and he’s taking many members of his cabinet with him. Davos is famous for being a gathering of heads of state as well as CEOs and other high-powered corporate executives. Considering Trump’s “drain the swamp” platform, it is a bit eye-raising that he will....More>>>

9 Must-Own Stocks That Have Paid Over a Century of Dividends

Dividend stock investing is inherently a long-term enterprise. After all, companies only pay their investors dividends once a quarter and dividend yields are calculated on an annualized basis. If you own a stock for only a few months, you’re not experiencing the full dividend potential. And if you only own a few weeks, there’s a chance you don’t get paid a dividend at....More>>>

Top Value Stocks To Invest In 2018

Mobileye (NYSE:MBLY) remains a difficult stock to value. The fast growth of driver-assisted systems and huge market opportunity is offset by a stock valuation already factoring in a ton of growth.

The end result is that the stock trades below $40 now following what was a solid Q3. Mobileye generally trades at the midpoint of the stock range since going public back in mid-2014. Again,....More>>>

UroGen Pharma Readies $45 Million IPO

Quick Take

Clinical-stage urological treatment company UroGen Pharma (Pending:URGN) has finalized proposed terms for its IPO, aiming to sell 3.46 million shares of common stock at a midpoint price of $13.00 per share.

The company is developing a potentially improved method to deliver bladder cancer and overactive bladder treatments.

While the market is forecasted....More>>>

UroGen Pharma Readies $45 Million IPO

Quick Take

Clinical-stage urological treatment company UroGen Pharma (Pending:URGN) has finalized proposed terms for its IPO, aiming to sell 3.46 million shares of common stock at a midpoint price of $13.00 per share.

The company is developing a potentially improved method to deliver bladder cancer and overactive bladder treatments.

While the market is forecasted....More>>>